Find and Pitch Jounalists, Get Your Story Covered

Tags: myelofibrosis inpatient to outpatient transitions medication reconciliation platelets platelet

	Profile	Recent Articles on Subject
1	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Final Thoughts - 2 days ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 30 days ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH - 3 days ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 8 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 9 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 10 months ago Ruxolitinib Combinations Reduce Spleen Volume in Myelofibrosis - 12 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 12 months ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Arcellx to present positive data on multiple myeloma treatments - 18 days ago Scotland first in UK to approve new myeloma treatment - 2 months ago Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 6 months ago
4	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 19 days ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - about 1 month ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 8 months ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - 12 months ago AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy - 12 months ago Prenatal Folate May Program Hematopoietic Stem Cell Function Into Adulthood - 12 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	FDA Rejection Delays Regeneron From Competing With J&J, Pfizer in Multiple Myeloma - 3 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Extends Approval of Fibryga to Include Bleeding Patients With Acquired Fibrinogen Deficiency - 4 months ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 4 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 5 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 8 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago FDA Grants Breakthrough Therapy Designation to Novel Drug for Progressive Pulmonary Fibrosis - about 1 year ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 11 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 11 months ago High NfL Levels Predict Greater MS Disability Within 2 Years - about 1 year ago
9	Pharmacy Times Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Challenges in Outpatient Transition For Myelofibrosis Care - 10 months ago Inpatient to Outpatient: Myelofibrosis Care - 11 months ago Challenges in Myelofibrosis: Red Blood Cell Transfusion Shortages - 11 months ago Blood Shortages Impacting Myelofibrosis Care - 11 months ago
10	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	Novartis Announces Positive Findings for Scemblix in Newly Diagnosed Chronic Myeloid Leukemia - 11 months ago

Journalists covering myelofibrosis